T1	Participants 104 123	metabolic syndrome.
T2	Participants 163 195	patients with metabolic syndrome
T3	Participants 449 555	subjects with metabolic syndrome were treated with allopurinol (n = 28) or placebo (n = 22) for one month.
T4	Participants 1578 1610	patients with metabolic syndrome
